
Enthusiastic Molecular biologist eager to contribute to team success through hard work, attention to detail and excellent organizational skills. A decade in academia made me a professional learner and problem solver. In my Ph.D. I worked on developing an anti-aging therapy. Specifically, I investigated how small diamine molecules promote healthier aging. Motivated to learn, grow and excel in R&D and Analytical fields.
Initiated collaboration with Martin Trebbin group specializing in ultrafast imaging. Together we developed a microfluidic platform for reconstitution of large membrane proteins in giant liposomes.
Developed a formulation of a face cream that reduced the production cost by 20% while improving emollient properties.
Prepared and submitted documents to Ministry of Health for product approval.
Research and analysis
Analytical and Problem-Solving skills
Presentation
Writing and editing skills
Troubleshooting of biological techniques
Good work ethic
First Author Publications:
1.Srivastava, V.(1), Zelmanovich, V.(1), Shukla, V.(1), Abergel, R.(1), Cohen, I., Ben-Sasson, S.
A., & Gross, E. (2022). Distinct designer diamines promote mitophagy, and thereby
enhance healthspan in C. elegans and protect human cells against oxidative damage.
Autophagy. (IF 16.02)
2.Romero-Afrima, L.(1), Zelmanovich, V.(1), Abergel, Z., Zuckerman, B., Shaked, M.,
Abergel, R., ... & Gross, E. (2020). Ferritin is regulated by a neuro-intestinal axis in the
nematode Caenorhabditis elegans. Redox biology, 28. (IF 11.8)
Other Publications:
3.Zuckerman, B., Abergel, Z., Zelmanovich, V., Romero, L., Abergel, R., Livshits, L., ... &
Gross, E. (2017). Characterization of gene expression associated with the adaptation of
the nematode C. elegans to hypoxia and reoxygenation stress reveals an unexpected
function of the neuroglobin GLB-5 in innate immunity. Free Radical Biology and
Medicine, 108, 858-873.
4.Gross, E., Soltesz, Z., Oda, S., Zelmanovich, V., Abergel, Z., & de Bono, M. (2014). GLOBIN-
5-dependent O2 responses are regulated by PDL-1/PrBP that targets prenylated
soluble guanylate cyclases to dendritic endings. Journal of Neuroscience, 34(50),
16726-16738.